Ashley Gallagher, MA

Jasmine Cutler, PharmD, CPh, assistant professor in the department of pharmacy practice at the Taneja College of Pharmacy, discusses role of education and accessibility in reproductive health.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, also addresses personalized care and the expanding responsibilities of pharmacists.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, discusses recent advancements in diabetes care.

In the evolving landscape of community pharmacy, the Prescription Shoppe emerged as a beacon of resilience and patient-centered care during the COVID-19 pandemic.

Jade Ranger, co-owner and pharmacist of the Prescription Shoppe, discusses how her pharmacy put patients first during the COVID-19 pandemic.

Alisha Reed, PharmD, founder of Your Self Care Prescription, LLC, discussed how pharmacists can implement wellness programs to reduce burnout.

Mark Garofoli, PharmD, BCGP, CPE, director of experiential learning at West Virginia University, discusses the potential of psuychedelic therapy in pharmacy.

Emily Leppien, PharmD, BCPS, BCPP, clinical associate professor of pharmacy practice at Binghamton University, discusses identifying potential red flags for substance use disorder.

National Adverse Drug Event Awareness Day occurs annually on March 24 to raise awareness about minimizing the risk of adverse events caused by medications.

Jeffrey Gudin, MD, faculty in the department of anesthesiology and pain management at the University of Miami, said topical analgesics are safer alternatives to systemic medications.

Darcy Aslett, PharmD, residency program director for PGY-1 community-based residency at St. Luke's Health System, discusses clinical services in pharmacies for underserved patients.

Ravi Patel, PharmD, MBA, MS, lead innovation advisor in the School of Pharmacy at the University of Pittsburgh, discusses challenges with new technology and the future of artificial intelligence in pharmacy.

Elizabeth Pogge, PharmD, professor in the College of Pharmacy at Midwestern University, discusses the safety and efficacy of anticoagulation for this population.

Ravi Patel, PharmD, MBA, MS, lead innovation advisor in the School of Pharmacy at the University of Pittsburgh, explains how artificial intelligence can be used in pharmacy.

Elizabeth Pogge, PharmD, professor in the College of Pharmacy at Midwestern University, discusses initiating anticoagulation for older adults as well as the risk-benefit balance of the therapy.

Sally Arif, PharmD, professor in the College of Pharmacy at Midwestern University, discusses how pharmacists can effectively communicate with diverse patients.

Jade Ranger, PharmD, co-owner and pharmacist at the Prescription Shoppe, discussed administering vaccines during the COVID-19 pandemic.

Pharmacists play a critical role in public education, and the potential for expanding clinical services is evident.

Jade Ranger, PharmD, discusses her experiences during the COVID-19 pandemic as one of the first pharmacies to receive the COVID-19 vaccines.

Jeffery Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, reflects on the COVID-19 pandemic 5 years later.

The new approval is an oral suspension for patients with hypertension and left ventricular hypertrophy and for the treatment of diabetic nephropathy.

Pharmacists are resilient, community-focused professionals who played a pivotal role in navigating the unprecedented challenges of the COVID-19 pandemic.

Because of their accessibility in the community, pharmacists can help to deliver balanced and individualized services and address social determinants of health.

The most commonly reported symptoms of long COVID include neurological, muscular, respiratory, and psychological.

Tirzepatide and semaglutide show long-term health care cost savings but, the high cost of the medications offset the savings.

Among the drugs presented, Biktarvy and lenacapavir, teropavimab, and zinlirvimab (LTZ) demonstrate rates of suppression of HIV, and vesatolimod is well tolerated.

These findings challenge the common assumption that older adults might struggle to use more advance medical devices.

This year’s meeting will take place from March 21 to 24 in Nashville, Tennessee.

Additional data shows that an investigational drug, given every 4 months with Apretude, kept viral levels suppressed for patients who were already on stable treatment.

These findings are shared as late-breaking data at the 32nd Conference on Retroviruses and Opportunistic Infections (CROI) being held in San Francisco, California.